Beyond PD-1/PD-L1, the expression of cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) in RCC tumor-infiltrating monocytes was identified as an independent prognostic factor in RCC patients and significantly associated with worse outcome (65). This evidence concerns the gene CTLA4 and neoplasm.